| HRA003043
(Controlled Access)
|
20 locally advanced oral squamous cell carcinoma patients were enrolled. Neoadjuvant immunochemotherapy (NAICT) was well-tolerated with low incidence of grade 3-4 adverse events (AEs) in three patients (15%). Using pathological evaluation for NAICT, the major pathologic response (MPR) rate was 60% (12/20), including 30% (6/20) pCR. MPR was archived in all 4 patients with combined positive score of PD-L1>10. Using radiographical evaluation, there were 10% of CR and 50% of PR. The pathological and radiographical response was consistent in linear regression analysis (P<0.001). The pathological response pattern to NAICT was scatter pattern in 92.9% (13/14) of patients, with multiple residual foci. Patients with higher TMB and more immune activation cells in biopsies tended to show higher MPR rate, respectively. More tertiary lymphoid structure was found in the post-NAICT surgical specimens than pre-NAICT biopsies (P=0.03), especially in the MPR group (P=0.009). |